College ter Beoordeling van Geneesmiddelen — Tekorten (CBG-MEB)
College ter Beoordeling van Geneesmiddelen — Tekorten is the official source of medicine shortage information for Netherlands (EU). Mederti checks its register daily and links every notice back to the original publication.
- Official register
- www.cbg-meb.nl
- Country
- Netherlands
- Notices tracked by Mederti
- 1,972
- Last checked
- 8 Aug 2026
Latest notices from CBG-MEB
- Capecitabine — active, medium, since 7 Aug 2026 (source)
- Rabiesvaccin — active, high, since 7 Aug 2026 (source)
- Rifabutine — active, medium, since 7 Aug 2026 (source)
- Tekenencefalitisvaccin — active, medium, since 7 Aug 2026 (source)
- Ipratropium — active, medium, since 7 Aug 2026 (source)
- Captopril — active, medium, since 7 Aug 2026 (source)
- Fenobarbital — active, medium, since 7 Aug 2026 (source)
- Dorzolamide — active, medium, since 7 Aug 2026 (source)
- Clobetasol — active, high, since 7 Aug 2026 (source)
- Valproinezuur — active, medium, since 7 Aug 2026 (source)
- Rasburicase — active, medium, since 7 Aug 2026 (source)
- Rifampicine — active, medium, since 7 Aug 2026 (source)
- Moroctocog Alfa — active, medium, since 7 Aug 2026 (source)
- Mycofenolzuur — active, medium, since 7 Aug 2026 (source)
- Methylprednisolon — active, medium, since 7 Aug 2026 (source)
Every CBG-MEB notice, searchable and alertable
Search Netherlands's full register alongside 50+ other countries — free for individual pharmacists and clinicians.
Create a free accountMederti is not affiliated with or endorsed by College ter Beoordeling van Geneesmiddelen — Tekorten. All notices remain the property of their publisher and are linked to the original source.